The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines after a safety concern was found to be unrelated ...
Novavax is already poised to benefit from a separate combined Covid-flu vaccine ... combined shot. Meanwhile, Moderna said last week that it plans to file for FDA approval of its own combo vaccine ...
The lifted hold applies to Novavax’s flu ... combo vaccine. A trial participant who’d received the shot in Jan. 2023 later developed motor neuropathy, or muscle weakness, leading the FDA ...
(Reuters) -The U.S ... hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines after a safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results